Clinical Trial Update: Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating mesenchymal stem cells predifferentiated in osteogenic direction for chronic periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis Chronic

Drugs mentioned

• Mesenchymal stem cells predifferentiated in osteogenic direction

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Periodontitis, Chronic | Phase 1, Phase 2 | Status: COMPLETED